The Use Of The Dot Strategy For Treatment Tuberculosis

This study was designed as a descriptive case series as it follows the progress of ten participants undergoing the same treatment with no control group. As this is a

People-Centered Tuberculosis Care Verses Standard Directly Observed Therapy: Study Protocol For a Cluster Randomized Controlled Trial

The Toronto Public health uses an observation-based treatment called DOT to anyone who is infected tuberculosis. Directly Observed Therapy is program that aids patient with their daily medications, assists them for medical appointments and monitors their health progress (TPH, 2015). The DOT worker is doing observation,

According to the Centers for Disease Control and Prevention (CDC) in 2014, 9.6 million Americans were infected with the Tuberculosis (TB) disease. Over the years many programs and initiatives have been implemented to decrease the occurrences of TB disease in America. As long individuals are educated on the prevention of tuberculosis fatal complications can be prevented through early treatment. The purpose of this paper is to discuss the description of Tuberculosis and the demographic of interest, determinants of health and how determinants contribute to the development of Tuberculosis, epidemiologic triangle, role of the community health nurse, and the World Health Organization that works to address

Farran, C., Gilley, D., McCann, J., Bienias, J., Lindeman, D., & Evans, D. (2007). Efficacy of

Upon completion of the data collection, 583 patients were assessed for inclusion into the study, 325 in the 2010 pre-implementation group and 258 in the 2013 post-implementation group. A total of 200 patients were randomized in each group (n=400); however, 69 (35%) and 63 (32%) were excluded from the 2010 group and 2013 group respectively. Sample demographics are described in Table 1.

Infectious diseases are one of the most challenging adversities that the human race faces. Diseases that once wiped out large populations are now well understood, preventative measures can be taken, and effective treatment methods provided. However, as science has evolved so have the infectious diseases that are seen. An example of an infectious disease that has been studied and continues to be seen today is Tuberculosis. Tuberculosis has been a health hazard for many centuries and was once an epidemic. Medical advances and studies have been able to enlighten not only the etiology, but also the mode of transmission, ways to diagnose, and ways to treat and/or manage infection.

These studies employ different research analysis methodologies to determine the most effective LSS treatment strategy. Up to date, level one evidence is considered best practice when evaluating evidence-based research and making clinical decisions. Therefore, a systematic and meta-analysis review published in March of 2015, that used only randomized control trials (RTCs) was identified as being highly relevant and potentially useful to the clinical question at

I chose to examine the case study regarding Tuberculosis (TB) and how the Directly Observed Treatment Shortcourse (DOTS) was used to help to reduce the incidence of the disease in China. According to the World Health Organization (WHO), in 2013, 9 million people became ill from TB and 1.5 million people died as a result of the disease (WHO, 2015). In China, tuberculosis is the leading infectious disease that causes death among young adults in that country (Center for Global Development, 2015). As a result of the DOTS program, China was able to reduce the incidence of new cases of TB by 95% and have a cure rate of 90% for those who were unsuccessfully treated in the past (Center for Global Development, 2015). The DOTS program has been effective in reducing the incidence of TB all over the world.

Tuberculosis (TB) remains a significant global public health issue, ranking as the second leading cause of mortality after the human immunodeficiency virus (HIV). In 2013, there were an estimated 9 million new cases and 1.5 million associated deaths.1 A substantial proportion of the world’s population is also affected by humanitarian crises each year, resulting in high numbers of both internally displaced persons (IDPs) and refugees.2 By the end of 2013 there were approximately 51.2 million people forcibly displaced (including 33.3 million IDPs), 6 million more than in the previous year.3 Despite a decline in worldwide TB prevalence over the last decade – largely attributed to effective diagnosis and treatment interventions – TB-associated

Tuberculosis is a prime leading health problem throughout the universe. It is the second utmost cause of death from a contagious agent killing nearly 20 million people each year. There are two major elements that are contributing to the current TB endemic and its combined morbidity and mortality include; growing human immunodeficiency virus outbreaks and rising prevalence of resistance of Mycobacterium tuberculosis strains of the most effective anti-TB drugs. Another causative to the development of resistance is the destitute quality of drugs, improper treatment management, patient non-cooperation and malabsorption due to other integral conditions. This paper is comprised of the pathophysiology of TB, etiology, diagnosis, signs and

In our study we found that; out of 81 patients enrolled in the study 34 patients

Progress tackling the TB burden is associated with Directly Observed Treatment – Short Course (DOTS) from the Stop TB Strategy, adopted by WHO in 1993. This strategy involves and addresses TB/HIV, multidrug-resistant TB and the needs of poor and vulnerable populations, strengthening primary care, engaging all care providers, empowering people with TB and communities with partnership, and enabling and promoting research. DOTS is a global TB control, reducing TB incidents by directly observing patients taking their drugs. Countries that have adopted the DOTS strategy have effectively treated a total of 51 million people since 1995 (The Global Fund To Fight AIDS, Tuberculosis and Malaria, 2014).

This particular case study is about controlling tuberculosis (TB) in china. At the moment tuberculosis is what causes most deaths in china. The case study discusses in length about the way china took part in an intervention to attempt to control. China set about implementing this intervention by trying to revitalizing its this was done by china revitalizing its previously unsuccessful tuberculosis program and instead launch the 10 year infectious and endemic disease control project to reduce its TB epidemic (Skolnik 2012). DOTS was recommended by the World Health Organization as a TB control strategy, this basically trained health workers in how to supply medication for individuals who were diagnosed with TB. According to the World Health Organization ‘’the most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it’’ Implementing the DOTS strategy secured the result that china attained a 95 percent rate of curing for people who were already diagnosed with TB, within just two years of adopting DOTS.

India, the second most populous country with over 1.31 billion people, has the highest burden of tuberculosis (TB) in the world, accounting for 20% of the global incidence of TB, and an even higher share of global incidence of multi–drug resistant (MDR) TB. With an estimated 2 million new cases of TB and 5, 00,000 TB-related deaths in India annually, those who got diagnosed with different forms of DR-TB were 35,385 cases but only 20,753 people started on multidrug-resistant TB (MDR-TB) treatment in 2013. The National Tuberculosis Program was launched in 1962, but suffered heavily continuing TB led mortality. Acknowledging this reality, a Revised National Tuberculosis Control Programme (RNTCP) was launched by the Government of India in 1997, however even today it does not comply with World Health Organization (WHO) recommendations.